The Union World Conference on Lung Health 2023

November 15, 2023 - November 18, 2023
Paris, France


Oxford Nanopore are sponsoring, exhibiting and presenting at this event.

The Oxford Nanopore Satellite symposium will take place on Friday 17th November at 07:15 - 08:15.

The session, chaired by Justin O'Grady, Senior Director, Translational Applications, will highlight the role of the Oxford Nanopore Technologies Drug-Resistant TB sequencing test in the rapid characterisation of drug resistance profiles directly from decontaminated sputum samples in diverse global settings.

Please check below for full speaker details and register to join the satellite session.

Please visit us at Booth #3330 if you are able to attend the event.


picture of Kristin Kremer

The Dream Fund project on nanopore sequencing for tuberculosis and other infectious diseases in low- and middle-income countries; first experiences from Kyrgyzstan

Kristin Kremer, Team Lead Diagnostics , KNCV Tuberculosis Foundation

Kristin Kremer is the Team Lead Diagnostics at KNCV Tuberculosis Foundation, coordinator of two proj...

picture of Tara Ness

Use of Nanopore Sequencing on Stool to Diagnose and Determine Drug Susceptibility of Tuberculosis

Tara Ness, Pediatric Infectious Diseases Fellow , Baylor of Medicine/Texas Children’s Hospital

Tara Ness (MD, MPH) is a Pediatric Infectious Diseases Fellow at Baylor College of Medicine. She is ...

picture of Uladzimir Antonenka

Streamlining of TB drug susceptibility testing of M. tuberculosis by integration of the BD MAX MDR-TB real-time PCR assay with NanoTB® (Oxford Nanopore Technologies) targeted next generation sequencing

Uladzimir Antonenka , Program Manager , Institute of Microbiology and Laboratory Medicine, WHO Supranational Reference Laboratory for Tuberculosis

Dr. Uladzimir Antonenka is a Program Manager at the Institute of Microbiology and Laboratory Medicin...